{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T16:12:05Z","timestamp":1794759125440,"version":"4.9.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018731","name":"Jiangsu Hengrui Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.xcrm.2025.102331","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:36:44Z","timestamp":1756996604000},"page":"102331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of henagliflozin on aging biomarkers in patients with type 2 diabetes: A multicenter, randomized, double-blind, placebo-controlled study"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1413-2293","authenticated-orcid":false,"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianfeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huoping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxia","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guigen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanying","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102331_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ecl.2021.05.013","article-title":"An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective","volume":"50","author":"Tinajero","year":"2021","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.xcrm.2025.102331_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrc2560","article-title":"Senescence-messaging secretome: SMS-ing cellular stress","volume":"9","author":"Kuilman","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102331_bib3","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/db14-1820","article-title":"Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity","volume":"64","author":"Palmer","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.xcrm.2025.102331_bib4","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1074\/jbc.REV120.008387","article-title":"Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks","volume":"295","author":"Perry","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.102331_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012325","article-title":"Repurposing SGLT-2 Inhibitors to Target Aging: Available Evidence and Molecular Mechanisms","volume":"23","author":"La Grotta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.102331_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41580-021-00411-4","article-title":"Molecular mechanisms of dietary restriction promoting health and longevity","volume":"23","author":"Green","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102331_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3945\/ajcn.111.024521","article-title":"Energy intake and leukocyte telomere length in young adults","volume":"95","author":"Kark","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.xcrm.2025.102331_bib8","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0048","article-title":"Nutrition, GH\/IGF-1 signaling, and cancer","volume":"31","author":"Fanti","year":"2024","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.xcrm.2025.102331_bib9","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/cvr\/cvad035","article-title":"Caloric restriction for the immunometabolic control of human health","volume":"119","author":"Procaccini","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.xcrm.2025.102331_bib10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41586-024-08329-5","article-title":"Lithocholic acid phenocopies anti-ageing effects of calorie restriction","volume":"643","author":"Qu","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102331_bib11","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/ejhf.3221","article-title":"Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trial","volume":"26","author":"Sattar","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.xcrm.2025.102331_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamacardio.2023.4664","article-title":"Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial","volume":"9","author":"Mc Causland","year":"2024","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.xcrm.2025.102331_bib13","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.119.044775","article-title":"Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58","volume":"142","author":"Bonaca","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2025.102331_bib14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/s43587-024-00642-y","article-title":"SGLT2 inhibition eliminates senescent cells and alleviates pathological aging","volume":"4","author":"Katsuumi","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.xcrm.2025.102331_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13596","article-title":"Geroscience-guided repurposing of FDA-approved drugs to target aging: A proposed process and prioritization","volume":"21","author":"Kulkarni","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.xcrm.2025.102331_bib16","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab079","article-title":"SGLT2 Inhibitors as Calorie Restriction Mimetics: Insights on Longevity Pathways and Age-Related Diseases","volume":"162","author":"Hoong","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.xcrm.2025.102331_bib17","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2337\/dc20-0028","article-title":"Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register","volume":"43","author":"Cheng","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2025.102331_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/dc21-1609","article-title":"Shortened Leukocyte Telomere Length Is Associated With Glycemic Progression in Type 2 Diabetes: A Prospective and Mendelian Randomization Analysis","volume":"45","author":"Cheng","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2025.102331_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2022.111694","article-title":"Effect of a lifestyle intervention on telomere length: A systematic review and meta-analysis","volume":"206","author":"Buttet","year":"2022","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.xcrm.2025.102331_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1152\/physiol.00003.2024","article-title":"New Insights into IGF-1 Signaling in the Heart","volume":"39","author":"Lee","year":"2024","journal-title":"Physiology"},{"key":"10.1016\/j.xcrm.2025.102331_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061368","article-title":"Insulin-like Growth Factor-1 and IGF Binding Proteins Predict All-Cause Mortality and Morbidity in Older Adults","volume":"9","author":"Zhang","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2025.102331_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2018.03.014","article-title":"IGFBP-3 plays an important role in senescence as an aging marker","volume":"59","author":"Hong","year":"2018","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.xcrm.2025.102331_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103010","article-title":"Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress","volume":"69","author":"Cai","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.xcrm.2025.102331_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-020-01359-z","article-title":"Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad","volume":"20","author":"Ekanayake","year":"2020","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.xcrm.2025.102331_bib25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s12276-020-0415-z","article-title":"beta-hydroxybutyrate and its metabolic effects on age-associated pathology","volume":"52","author":"Han","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.xcrm.2025.102331_bib26","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1111\/dom.15782","article-title":"Association patterns of ketone bodies with the risk of adverse outcomes according to diabetes status","volume":"26","author":"Li","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.xcrm.2025.102331_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4103\/jfmpc.jfmpc_644_21","article-title":"Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis","volume":"11","author":"Dutta","year":"2022","journal-title":"J. Family Med. Prim. Care"},{"key":"10.1016\/j.xcrm.2025.102331_bib28","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/dom.14314","article-title":"Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial","volume":"23","author":"Lu","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.xcrm.2025.102331_bib29","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1111\/dom.14389","article-title":"Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial","volume":"23","author":"Weng","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.xcrm.2025.102331_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.869414","article-title":"Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic beta Cells","volume":"13","author":"Murakami","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.xcrm.2025.102331_bib31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases","volume":"14","author":"Franceschi","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.xcrm.2025.102331_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101422","article-title":"Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?","volume":"71","author":"Santoro","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.xcrm.2025.102331_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.867098","article-title":"Escaping Death: How Cancer Cells and Infected Cells Resist Cell-Mediated Cytotoxicity","volume":"13","author":"Tuomela","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102331_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/acel.12384","article-title":"Reduced naive CD8(+) T-cell priming efficacy in elderly adults","volume":"15","author":"Briceno","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.xcrm.2025.102331_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154754","article-title":"Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling","volume":"133","author":"Ding","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102331_bib36","article-title":"The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102331_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2337\/dc22-1339","article-title":"Association of Serum Uric Acid With All-Cause and Cardiovascular Mortality in Diabetes","volume":"46","author":"Li","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2025.102331_bib38","article-title":"The relationship between serum uric acid and accelerated aging in middle-aged and older adults: a prospective cohort study based on CHARLS","volume":"29","author":"Shi","year":"2025","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.xcrm.2025.102331_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02520-8","article-title":"SGLT2 inhibitor downregulates ANGPTL4 to mitigate pathological aging of cardiomyocytes induced by type 2 diabetes","volume":"23","author":"Wen","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.xcrm.2025.102331_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115213","article-title":"Dapagliflozin prevents oxidative stress-induced endothelial dysfunction via sirtuin 1 activation","volume":"165","author":"Zhou","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.xcrm.2025.102331_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1124\/jpet.121.001251","article-title":"Empagliflozin Improves the MicroRNA Signature of Endothelial Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes","volume":"384","author":"Mone","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.xcrm.2025.102331_bib42","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.cmet.2023.10.005","article-title":"Dietary restriction of isoleucine increases healthspan and lifespan of genetically heterogeneous mice","volume":"35","author":"Green","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2025.102331_bib43","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","article-title":"The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders","volume":"56","author":"Czubowicz","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.xcrm.2025.102331_bib44","article-title":"Lipid Deposition Profiles Influence Foreign Body Responses","volume":"35","author":"Schreib","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2025.102331_bib45","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20230374","article-title":"The importance of thiamine (vitamin B1) in humans","volume":"43","author":"Mrowicka","year":"2023","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.xcrm.2025.102331_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02515-5","article-title":"The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better","volume":"23","author":"Loria","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.xcrm.2025.102331_bib47","article-title":"Impact of SGLT2 Inhibitors on Very Elderly Population with Heart Failure with Reduce Ejection Fraction: Real Life Data","volume":"12","author":"Balaguer","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.xcrm.2025.102331_bib48","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/ehf2.14947","article-title":"Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues","volume":"12","author":"Fang","year":"2025","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.xcrm.2025.102331_bib49","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2174\/0113816128347041241129055001","article-title":"Use of SGLT2 Inhibitors in Frail Older Adults is Associated with Increased Survival: A Retrospective Study","volume":"31","author":"Ragusa","year":"2025","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.xcrm.2025.102331_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107055","article-title":"Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease","volume":"200","author":"Mone","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xcrm.2025.102331_bib51","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1161\/HYPERTENSIONAHA.123.20598","article-title":"Functional and Clinical Importance of SGLT2-inhibitors in Frailty: From the Kidney to the Heart","volume":"80","author":"Santulli","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.xcrm.2025.102331_bib52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14796678.2024.2433381","article-title":"GLP-1 receptor agonists and SGLT2 inhibitors: new anti-aging tools?","volume":"21","author":"Santulli","year":"2025","journal-title":"Future Cardiol."},{"key":"10.1016\/j.xcrm.2025.102331_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2024.08.001","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug?","volume":"5","author":"Mone","year":"2024","journal-title":"Lancet. Healthy Longev."},{"key":"10.1016\/j.xcrm.2025.102331_bib54","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/30.10.e47","article-title":"Telomere measurement by quantitative PCR","volume":"30","author":"Cawthon","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102331_bib55","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xcrm.2025.102331_bib56","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.xcrm.2025.102331_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.175","article-title":"Wekemo Bioincloud: A user-friendly platform for meta-omics data analyses","volume":"3","author":"Gao","year":"2024","journal-title":"Imeta"},{"key":"10.1016\/j.xcrm.2025.102331_bib58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102331_bib59","doi-asserted-by":"crossref","first-page":"76930","DOI":"10.1016\/j.aca.2013.01.022","article-title":"A consensus orthogonal partial least squares discriminant analysis (OPLS-DA) strategy for multiblock Omics data fusion","volume":"769","author":"Boccard","year":"2013","journal-title":"Anal. Chim. Acta"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:40:33Z","timestamp":1765888833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125004045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2666379125004045"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102331","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of henagliflozin on aging biomarkers in patients with type 2 diabetes: A multicenter, randomized, double-blind, placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102331"}}